constructiondive.com ›
post › joq6dls
January 14, 2026
As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on details as well as its potential financial impact.
nasdaq.com ›
post › 78014328448310702242
September 12, 2025
Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of AbbVie Inc (Symbol: ABBV) were yielding above the 3% mark based on its quarterly dividend (annualized to $6.56), with the stock changing hands as low as $218.24 on …
constructiondive.com ›
post › 16367287521640502474
August 18, 2025
The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.
nasdaq.com ›
post › 81097388748351639125
August 13, 2025
(RTTNews) - AbbVie (ABBV) will invest $195 million to expand its North Chicago, Illinois manufacturing facility, boosting domestic production of active pharmaceutical ingredients or APIs.
nasdaq.com ›
post › 82994878143411503520
August 11, 2025
At Holdings Channel, we have reviewed the latest batch of the 28 most recent 13F filings for the 06/30/2025 reporting period, and noticed that AbbVie Inc (Symbol: ABBV) was held by 15 of these funds. When hedge fund managers appear to be thinking alike, we fi…
nasdaq.com ›
post › 30972113338797468073
August 10, 2025
Key PointsAbbVie is witnessing robust growth as it moves on from its Humira patent losses.
cnbc.com ›
post › 91347957424302240844
June 17, 2025
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.
nasdaq.com ›
post › 25798602212985155579
June 17, 2025
(RTTNews) - Genentech, a member of the Roche Group (RHHBY), and AbbVie announced that The Phase III VERONA study, which evaluated Venclexta or venetoclax in combination with azacitidine for patients with previously untreated higher-risk myelodysplastic syndrom…
nasdaq.com ›
post › 65375620048355899747
May 12, 2025
At Holdings Channel, we have reviewed the latest batch of the 33 most recent 13F filings for the 03/31/2025 reporting period, and noticed that AbbVie Inc (Symbol: ABBV) was held by 18 of these funds. When hedge fund managers appear to be thinking alike, we fi…
marketwatch.com ›
post › 67001794528128175964
April 25, 2025
AbbVie took a little shot at the Trump administration’s trade policy, as the drugmaker said Friday that rather than tariffs, tax reform is the key to boosting U.S. manufacturing.
nasdaq.com ›
post › 97257783381517666349
April 25, 2025
(RTTNews) - AbbVie (ABBV) Friday reported lower earnings for the first quarter primarily due to higher expenses. The pharma giant posted 8.4% growth in revenues. It also raised its annual profit outlook.
nasdaq.com ›
post › 68848013723596938672
April 14, 2025
AbbVie is scheduled to report its first-quarter results this month, with analysts anticipating a modest growth in earnings.
cnbc.com ›
post › 27946528352129466308
April 11, 2025
Carter breaks down the charts on large-cap pharmaceutical manufacturer AbbVie.
cnbc.com ›
post › 49926832178318380062
April 9, 2025
These are the stocks posting the largest moves in midday trading.
nasdaq.com ›
post › 42783896172224269626
April 8, 2025
(RTTNews) - AbbVie (ABBV) announced that the European Commission granted marketing authorization to RINVOQ for the treatment of giant cell arteritis in adult patients. RINVOQ is the first and only oral JAK inhibitor approved in the EU, as well as Iceland, Liec…
